XERS
Xeris Biopharma Holdings, Inc.
Company overview
- Market capitalization
- $1.79B
- Employees
- 435
- Latest publication
- 2026-09-29
About Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q4 20242024-12-31 · USD | Q4 20182018-12-31 · USD | Q3 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 92,100,000USD | 83,127,000USD | 85,807,000USD | 74,380,000USD | 71,539,000USD | 60,099,000USD | 801,000USD | 582,000USD |
| Cost Of Revenue | 12,512,000USD | 13,284,000USD | 19,079,000USD | 10,996,000USD | 14,609,000USD | 9,478,000USD | 42,000USD | 15,520,000USD |
| Gross Profit | 79,588,000USD | 69,843,000USD | 66,728,000USD | 63,384,000USD | 56,930,000USD | 50,621,000USD | 759,000USD | 582,000USD |
| Research Development | 10,669,000USD | 8,783,000USD | 7,874,000USD | 7,483,000USD | 8,055,000USD | 6,092,000USD | 12,390,000USD | 10,875,000USD |
| Selling General Administrative | 61,035,000USD | 53,144,000USD | 47,502,000USD | 46,459,000USD | 44,393,000USD | 40,139,000USD | 8,725,000USD | 4,650,000USD |
| Other Operating Expenses | 2,711,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 74,415,000USD | 61,927,000USD | 49,955,000USD | 56,653,000USD | 52,448,000USD | 48,942,000USD | 21,115,000USD | 15,525,000USD |
| Operating Income | 5,173,000USD | 7,916,000USD | 16,773,000USD | 6,731,000USD | 4,482,000USD | 1,679,000USD | -20,314,000USD | -14,943,000USD |
| Total Other Income Expense Net | -36,274,000USD | -5,682,000USD | -5,692,000USD | -6,110,000USD | -6,410,000USD | -6,792,000USD | -105,000USD | 176,000USD |
| Interest Expense | 6,947,000USD | 6,884,000USD | 7,153,000USD | 7,268,000USD | 7,358,000USD | 7,703,000USD | 1,055,000USD | 737,000USD |
| Income Before Tax | -31,101,000USD | 2,234,000USD | 11,081,000USD | 621,000USD | -1,928,000USD | -5,113,000USD | -20,419,000USD | -14,767,000USD |
| Income Tax Expense | 0USD | — | — | — | — | — | 881,000USD | 737,000USD |
| Net Income | -31,101,000USD | 2,234,000USD | 11,081,000USD | 621,000USD | -1,928,000USD | -5,113,000USD | -20,419,000USD | -14,767,000USD |
| Interest Income | — | 1,202,000USD | 1,461,000USD | 1,158,000USD | 948,000USD | 910,000USD | — | — |
| Net Interest Income | — | -5,682,000USD | -5,692,000USD | -6,110,000USD | -6,410,000USD | -6,793,000USD | — | — |
| Tax Provision | — | 0USD | 0USD | 0USD | 0USD | 0USD | — | — |
| Net Income From Continuing Ops | — | 2,234,000USD | 11,081,000USD | 621,000USD | -1,928,000USD | -5,113,000USD | -20,419,000USD | -15,218,000USD |
| Ebit | — | 9,118,000USD | 11,081,000USD | 7,889,000USD | 5,430,000USD | 2,590,000USD | -19,364,000USD | -14,030,000USD |
| Ebitda | — | 12,328,000USD | 14,127,000USD | 11,078,000USD | 8,594,000USD | 5,723,000USD | -19,190,000USD | -14,025,000USD |
| Depreciation And Amortization | — | 3,210,000USD | 3,046,000USD | 3,189,000USD | 3,164,000USD | 3,133,000USD | 174,000USD | 5,000USD |
| Reconciled Depreciation | — | 3,210,000USD | 3,197,000USD | 3,189,000USD | 3,164,000USD | 3,133,000USD | 174,000USD | 5,000USD |
| Unclassified Operating Expenses | — | — | -5,421,000USD | 2,711,000USD | — | 2,711,000USD | — | — |
| Minority Interest | — | — | — | — | — | — | 0USD | 0USD |
| Discontinued Operations | — | — | — | — | — | — | 0USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | -20,419,000USD | -14,767,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 462,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|
| Total Revenue | 291,845,000USD | 1,556,000USD | 1,075,000USD |
| Cost Of Revenue | 53,412,000USD | 4,000USD | 8,000USD |
| Gross Profit | 238,433,000USD | 1,552,000USD | 1,067,000USD |
| Research Development | 31,165,000USD | 20,166,000USD | 10,238,000USD |
| Selling General Administrative | 182,372,000USD | 8,015,000USD | 4,060,000USD |
| Total Operating Expenses | 213,537,000USD | 28,181,000USD | 14,298,000USD |
| Operating Income | 24,896,000USD | -26,629,000USD | -13,231,000USD |
| Interest Income | 4,742,000USD | 124,000USD | 5,000USD |
| Interest Expense | 29,084,000USD | 2,000USD | 2,000USD |
| Net Interest Income | -24,342,000USD | 122,000USD | 3,000USD |
| Income Before Tax | 554,000USD | -26,554,000USD | -13,209,000USD |
| Tax Provision | 0USD | — | — |
| Net Income | 554,000USD | -26,554,000USD | -13,209,000USD |
| Net Income From Continuing Ops | 554,000USD | -26,554,000USD | -13,209,000USD |
| Ebit | 554,000USD | -26,554,000USD | -13,207,000USD |
| Ebitda | 12,710,000USD | -26,377,000USD | -13,091,000USD |
| Depreciation And Amortization | 12,156,000USD | 177,000USD | 116,000USD |
| Reconciled Depreciation | 12,693,000USD | 177,000USD | — |
| Total Other Income Expense Net | -24,342,000USD | 75,000USD | 22,000USD |
| Income Tax Expense | — | 1,000USD | -3,000USD |
| Net Income Applicable To Common Shares | — | -26,554,000USD | -13,209,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 411,905,000USD | 392,013,000USD | 383,527,000USD | 370,191,000USD | 334,686,000USD | 315,453,000USD | 323,060,000USD | 321,104,000USD |
| Cash And Equivalents | 121,747,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 274,757,000USD | 251,682,000USD | 240,313,000USD | 224,017,000USD | 185,578,000USD | 163,494,000USD | 167,662,000USD | 162,799,000USD |
| Other Non Current Assets | 5,025,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 421,639,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 189,568,000USD | 118,593,000USD | 109,574,000USD | 116,200,000USD | 95,171,000USD | 95,072,000USD | 100,443,000USD | 91,013,000USD |
| Other Current Liabilities | 4,976,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 12,722,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -9,734,000USD | 13,011,000USD | 13,689,000USD | -861,000USD | -19,304,000USD | -35,128,000USD | -29,615,000USD | -28,323,000USD |
| Total Equity Including Noncontrolling Interest | -9,734,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 63,783,000USD | — | — | — | — | 11,959,000USD | 15,102,000USD | 15,057,000USD |
| Long Term Debt | 188,807,000USD | 221,224,000USD | 220,335,000USD | 219,469,000USD | 218,626,000USD | 217,805,000USD | 217,006,000USD | 216,227,000USD |
| Net Receivables | 58,105,000USD | 56,295,000USD | 51,050,000USD | 53,751,000USD | 53,048,000USD | 46,330,000USD | 40,415,000USD | 41,138,000USD |
| Inventory | 80,930,000USD | 74,234,000USD | 68,673,000USD | 67,462,000USD | 67,282,000USD | 52,690,000USD | 48,175,000USD | 45,119,000USD |
| Property Plant Equipment Net | 26,607,000USD | 26,982,000USD | 27,057,000USD | 27,209,000USD | 27,687,000USD | 27,791,000USD | 28,211,000USD | 28,371,000USD |
| Goodwill | 22,859,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 82,657,000USD | 85,368,000USD | 88,078,000USD | 90,789,000USD | 93,500,000USD | 96,211,000USD | 98,921,000USD | 101,632,000USD |
| Accounts Payable | 9,337,000USD | 11,467,000USD | 3,076,000USD | 6,527,000USD | 9,462,000USD | 6,352,000USD | 2,290,000USD | 7,451,000USD |
| Short Term Debt | 6,310,000USD | 6,271,000USD | 6,232,000USD | 6,194,000USD | 6,156,000USD | 18,076,000USD | 21,182,000USD | 21,099,000USD |
| Common Stock | 18,000USD | 18,000USD | 17,000USD | 17,000USD | 16,000USD | 16,000USD | 15,000USD | 15,000USD |
| Retained Earnings | -700,174,000USD | -669,073,000USD | -671,307,000USD | -682,388,000USD | -683,009,000USD | -681,081,000USD | -671,861,000USD | -666,748,000USD |
| Accumulated Other Comprehensive Income | -10,000USD | -24,000USD | -25,000USD | -25,000USD | -24,000USD | -25,000USD | -25,000USD | -16,000USD |
| Other Current Assets | — | 9,403,000USD | 9,548,000USD | 11,206,000USD | 5,963,000USD | 6,034,000USD | 7,451,000USD | 7,140,000USD |
| Total Liab | — | 379,002,000USD | 369,838,000USD | 371,052,000USD | 353,990,000USD | 350,581,000USD | 352,675,000USD | 349,427,000USD |
| Other Current Liab | — | 100,855,000USD | 100,266,000USD | 103,479,000USD | 79,553,000USD | 70,644,000USD | 76,971,000USD | 62,463,000USD |
| Capital Stock | — | 18,000USD | 17,000USD | 17,000USD | 16,000USD | 16,000USD | 15,000USD | 15,000USD |
| Good Will | — | 22,859,000USD | 22,859,000USD | 22,859,000USD | 22,859,000USD | 22,859,000USD | 22,859,000USD | 22,859,000USD |
| Cash | — | 111,750,000USD | 111,042,000USD | 91,598,000USD | 59,285,000USD | 58,440,000USD | 71,621,000USD | 59,232,000USD |
| Cash And Short Term Investments | — | 111,750,000USD | 111,042,000USD | 91,598,000USD | 59,285,000USD | 58,440,000USD | 71,621,000USD | 69,402,000USD |
| Net Debt | — | -74,421,000USD | -73,279,000USD | -53,413,000USD | 197,938,000USD | 210,311,000USD | 199,826,000USD | 211,733,000USD |
| Short Long Term Debt Total | — | 37,329,000USD | 37,763,000USD | 38,185,000USD | 257,223,000USD | 268,751,000USD | 271,447,000USD | 270,965,000USD |
| Property Plant Equipment Gross | — | 35,496,000USD | 35,234,000USD | 35,051,000USD | 35,191,000USD | 35,369,000USD | 35,474,000USD | 35,321,000USD |
| Common Stock Shares Outstanding | — | 177,631,154shares | 180,071,915shares | 177,617,307shares | 155,972,048shares | 152,445,935shares | 149,092,881shares | 148,994,000shares |
| Non Current Assets Total | — | 140,331,000USD | 143,214,000USD | 146,174,000USD | 149,108,000USD | 151,959,000USD | 155,398,000USD | 158,305,000USD |
| Non Current Liabilities Total | — | 260,409,000USD | 260,264,000USD | 254,852,000USD | 258,819,000USD | 255,509,000USD | 252,232,000USD | 258,414,000USD |
| Non Current Liabilities Other | — | 8,127,000USD | 8,398,000USD | 3,392,000USD | 7,752,000USD | 4,834,000USD | 1,967,000USD | 8,548,000USD |
| Non Currrent Assets Other | — | 1,101,000USD | 5,220,000USD | 5,317,000USD | 5,062,000USD | 975,000USD | 1,284,000USD | 5,443,000USD |
| Net Working Capital | — | 133,089,000USD | 130,739,000USD | 107,817,000USD | 90,407,000USD | 68,422,000USD | 67,219,000USD | 71,786,000USD |
| Unclassified Non Current Assets | — | 4,021,000USD | — | — | — | 4,123,000USD | 4,123,000USD | — |
| Unclassified Non Current Liabilities | — | 31,058,000USD | 31,531,000USD | 31,991,000USD | 32,441,000USD | 32,870,000USD | 33,259,000USD | 33,639,000USD |
| Unclassified Equity | — | 682,072,000USD | 684,987,000USD | 681,518,000USD | 663,697,000USD | 645,946,000USD | 642,241,000USD | 638,411,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | -11,959,000USD | -15,102,000USD | -15,057,000USD |
| Short Term Investments | — | — | — | — | — | — | 0USD | 10,170,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 383,527,000USD | 323,060,000USD | 322,602,000USD | 344,522,000USD | 304,361,000USD | 108,987,000USD | 108,987,000USD | 120,028,000USD |
| Intangible Assets | 88,078,000USD | 98,921,000USD | 109,764,000USD | 120,607,000USD | 131,450,000USD | — | — | — |
| Other Current Assets | 9,548,000USD | 7,451,000USD | 5,778,000USD | 9,287,000USD | 4,589,000USD | 5,065,000USD | 4,119,000USD | 2,397,000USD |
| Total Liab | 369,838,000USD | 352,675,000USD | 329,384,000USD | 299,335,000USD | 209,130,000USD | 94,551,000USD | 94,551,000USD | 44,622,000USD |
| Total Stockholder Equity | 13,689,000USD | -29,615,000USD | -6,782,000USD | 45,187,000USD | 95,231,000USD | 14,436,000USD | 14,436,000USD | 75,406,000USD |
| Other Current Liab | 100,266,000USD | 76,971,000USD | 80,133,000USD | 67,435,000USD | 70,116,000USD | 21,735,000USD | 21,735,000USD | 860,000USD |
| Common Stock | 17,000USD | 15,000USD | 14,000USD | 14,000USD | 13,000USD | 3,000USD | 3,000USD | 2,000USD |
| Capital Stock | 17,000USD | 15,000USD | 14,000USD | 14,000USD | 13,000USD | 6,000USD | 3,000USD | 2,000USD |
| Retained Earnings | -671,307,000USD | -671,861,000USD | -617,025,000USD | -554,770,000USD | -460,110,000USD | -246,245,000USD | -246,245,000USD | -120,665,000USD |
| Good Will | 22,859,000USD | 22,859,000USD | 22,859,000USD | 22,859,000USD | 22,859,000USD | 0USD | — | — |
| Cash | 111,042,000USD | 71,621,000USD | 67,449,000USD | 121,966,000USD | 67,271,000USD | 19,519,000USD | 19,519,000USD | 45,716,000USD |
| Cash And Short Term Investments | 111,042,000USD | 71,621,000USD | 72,451,000USD | 121,966,000USD | 102,433,000USD | 75,549,000USD | 75,549,000USD | 112,633,000USD |
| Total Current Assets | 240,313,000USD | 167,662,000USD | 156,264,000USD | 186,818,000USD | 142,596,000USD | 87,483,000USD | 87,483,000USD | 117,899,000USD |
| Total Current Liabilities | 109,574,000USD | 100,443,000USD | 95,193,000USD | 73,621,000USD | 79,040,000USD | 27,338,000USD | 27,338,000USD | 10,172,000USD |
| Net Debt | -73,279,000USD | 199,826,000USD | 161,742,000USD | 76,091,000USD | 20,796,000USD | 38,786,000USD | 38,786,000USD | -13,826,000USD |
| Short Term Debt | 6,232,000USD | 21,182,000USD | 3,495,000USD | 1,580,000USD | 1,580,000USD | — | — | 8,214,000USD |
| Short Long Term Debt Total | 37,763,000USD | 271,447,000USD | 229,191,000USD | 198,057,000USD | 88,067,000USD | 58,305,000USD | 58,305,000USD | 40,104,000USD |
| Long Term Debt | 220,335,000USD | 217,006,000USD | 190,932,000USD | 187,075,000USD | 88,067,000USD | 87,021,000USD | 58,305,000USD | 31,890,000USD |
| Net Receivables | 51,050,000USD | 40,415,000USD | 39,197,000USD | 30,830,000USD | 17,456,000USD | 4,693,000USD | 5,639,000USD | 2,869,000USD |
| Inventory | 68,673,000USD | 48,175,000USD | 38,838,000USD | 24,735,000USD | 18,118,000USD | 2,176,000USD | 2,176,000USD | — |
| Accounts Payable | 3,076,000USD | 2,290,000USD | 11,565,000USD | 4,606,000USD | 8,924,000USD | 5,603,000USD | 5,603,000USD | 866,000USD |
| Property Plant Equipment Net | 27,057,000USD | 28,211,000USD | 29,175,000USD | 9,508,000USD | 6,627,000USD | 7,853,000USD | 7,853,000USD | 2,034,000USD |
| Property Plant Equipment Gross | 35,234,000USD | 35,474,000USD | 35,211,000USD | 28,375,000USD | 10,762,000USD | 6,707,000USD | 7,853,000USD | 2,034,000USD |
| Accumulated Other Comprehensive Income | -25,000USD | -25,000USD | -25,000USD | -23,000USD | -31,000USD | 43,000USD | 43,000USD | -52,000USD |
| Common Stock Shares Outstanding | 172,742,720shares | 146,773,000shares | 137,674,857shares | 135,628,721shares | 79,027,062shares | 26,110,297shares | 26,110,297shares | 12,045,999shares |
| Non Current Assets Total | 143,214,000USD | 155,398,000USD | 166,338,000USD | 157,704,000USD | 161,765,000USD | 21,504,000USD | 21,504,000USD | 2,129,000USD |
| Non Current Liabilities Total | 260,264,000USD | 252,232,000USD | 234,191,000USD | 225,714,000USD | 130,090,000USD | 67,213,000USD | 67,213,000USD | 34,450,000USD |
| Non Current Liabilities Other | 8,398,000USD | 1,967,000USD | 6,227,000USD | 25,719,000USD | 30,198,000USD | 3,533,000USD | 8,908,000USD | 2,560,000USD |
| Non Currrent Assets Other | 5,220,000USD | -4,808,000USD | 4,540,000USD | 4,730,000USD | 829,000USD | 420,000USD | 420,000USD | 95,000USD |
| Net Working Capital | 130,739,000USD | 67,219,000USD | 61,071,000USD | 113,197,000USD | 63,556,000USD | 124,005,000USD | 60,145,000USD | 107,727,000USD |
| Unclassified Non Current Liabilities | 31,531,000USD | 33,259,000USD | 37,032,000USD | -16,317,000USD | -30,198,000USD | -40,132,000USD | -9,308,000USD | -2,560,000USD |
| Unclassified Equity | 684,987,000USD | 642,241,000USD | 610,240,000USD | 599,952,000USD | 555,346,000USD | 260,629,000USD | 260,632,000USD | 196,119,000USD |
| Other Assets | — | -6,092,000USD | — | 4,730,000USD | 829,000USD | 232,000USD | 420,000USD | 95,000USD |
| Short Long Term Debt | — | 15,102,000USD | — | — | — | — | — | — |
| Short Term Investments | — | 0USD | 5,002,000USD | 0USD | 35,162,000USD | 56,030,000USD | 56,030,000USD | 66,917,000USD |
| Unclassified Non Current Assets | — | 5,407,000USD | — | -4,730,000USD | — | 12,999,000USD | — | — |
| Unclassified Current Liabilities | — | -15,102,000USD | — | -64,777,000USD | -1,580,000USD | — | — | — |
| Other Liab | — | — | — | 29,237,000USD | 42,023,000USD | 10,162,000USD | 8,908,000USD | 2,560,000USD |
| Current Deferred Revenue | — | — | — | 64,777,000USD | — | — | — | 232,000USD |
| Net Tangible Assets | — | — | — | -98,279,000USD | -59,078,000USD | 33,761,000USD | 14,436,000USD | 75,406,000USD |
| Deferred Long Term Liab | — | — | — | — | — | 6,629,000USD | 400,000USD | — |
| Long Term Investments | — | — | — | — | — | 0USD | 13,231,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 2,234,000USD | 11,081,000USD | 621,000USD | -1,928,000USD | -9,220,000USD | -5,113,000USD | -15,738,000USD | -15,005,000USD |
| Depreciation | 3,210,000USD | 3,046,000USD | 3,049,000USD | 3,164,000USD | 3,143,000USD | 3,133,000USD | 2,678,000USD | 3,154,000USD |
| Stock Based Compensation | 4,140,000USD | 5,272,000USD | 7,643,000USD | 5,008,000USD | 4,443,000USD | 3,595,000USD | 6,768,000USD | 4,233,000USD |
| Other Non Cash Items | 889,000USD | 1,017,000USD | 983,000USD | 820,000USD | 844,000USD | 834,000USD | -7,709,000USD | -92,000USD |
| Change To Account Receivables | -5,245,000USD | 2,701,000USD | -703,000USD | -6,718,000USD | -5,915,000USD | 723,000USD | 1,302,000USD | -5,026,000USD |
| Change To Inventory | 851,000USD | -4,011,000USD | -4,085,000USD | -7,573,000USD | -3,617,000USD | -3,137,000USD | -1,048,000USD | -2,265,000USD |
| Change In Working Capital | -603,000USD | -373,000USD | 6,136,000USD | -6,882,000USD | -9,241,000USD | -474,000USD | 9,020,000USD | -3,387,000USD |
| Total Cash From Operating Activities | 9,870,000USD | 20,043,000USD | 18,432,000USD | 182,000USD | -10,031,000USD | 1,975,000USD | -8,305,000USD | -10,348,000USD |
| Capital Expenditures | -325,000USD | -333,000USD | -363,000USD | -279,000USD | -13,000USD | -220,000USD | -87,000USD | -397,000USD |
| Free Cash Flow | 9,545,000USD | 19,710,000USD | 18,069,000USD | -97,000USD | -10,044,000USD | 1,755,000USD | -8,392,000USD | -10,745,000USD |
| Total Cashflows From Investing Activities | -325,000USD | -333,000USD | -71,000USD | -279,000USD | -13,000USD | 10,016,000USD | 9,914,000USD | 4,603,000USD |
| Total Cash From Financing Activities | -8,837,000USD | -266,000USD | 13,850,000USD | 942,000USD | -3,137,000USD | 398,000USD | -83,000USD | 659,000USD |
| Sale Purchase Of Stock | -17,017,000USD | -1,540,000USD | -478,000USD | -860,000USD | -7,998,000USD | -166,000USD | -83,000USD | -51,000USD |
| Issuance Of Capital Stock | 7,333,000USD | — | — | — | 0USD | — | — | — |
| Change In Cash | 708,000USD | 19,444,000USD | 32,211,000USD | 845,000USD | -13,181,000USD | 12,389,000USD | 1,526,000USD | -5,086,000USD |
| Begin Period Cash Flow | 111,042,000USD | 95,619,000USD | 63,408,000USD | 62,563,000USD | 75,744,000USD | 63,355,000USD | 61,829,000USD | 62,690,000USD |
| End Period Cash Flow | 111,750,000USD | 115,063,000USD | 95,619,000USD | 63,408,000USD | 62,563,000USD | 75,744,000USD | 63,355,000USD | 57,604,000USD |
| Unclassified Financing Cash Flow | 8,180,000USD | 1,274,000USD | — | 6,663,000USD | — | — | -9,914,000USD | — |
| Investments | — | 0USD | -71,000USD | -279,000USD | -13,000USD | 10,016,000USD | 9,914,000USD | 4,603,000USD |
| Net Borrowings | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Other Cashflows From Investing Activities | — | — | 292,000USD | -292,000USD | — | -220,000USD | — | 5,000,000USD |
| Other Cashflows From Financing Activities | — | — | 13,850,000USD | -4,861,000USD | 4,861,000USD | 564,000USD | 9,914,000USD | 710,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -3,324,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -4,603,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 554,000USD | -54,836,000USD | -62,255,000USD | -94,660,000USD | -122,725,000USD | -91,140,000USD | -125,580,000USD | -60,080,000USD |
| Depreciation | 12,156,000USD | 12,625,000USD | 13,160,000USD | 12,668,000USD | 1,879,000USD | 1,467,000USD | 1,078,000USD | 320,000USD |
| Stock Based Compensation | 22,366,000USD | 18,363,000USD | 10,716,000USD | 12,160,000USD | 11,381,000USD | 8,273,000USD | 6,484,000USD | 1,728,000USD |
| Other Non Cash Items | 3,910,000USD | -2,045,000USD | -1,101,000USD | 3,515,000USD | 961,000USD | 3,104,000USD | 948,000USD | 560,000USD |
| Change To Account Receivables | -10,635,000USD | -1,218,000USD | -8,367,000USD | -13,374,000USD | -6,237,000USD | -2,182,000USD | -3,059,000USD | -1,670,000USD |
| Change To Inventory | -19,286,000USD | -8,782,000USD | -14,804,000USD | -7,465,000USD | -7,418,000USD | -5,143,000USD | -2,176,000USD | 4,042,000USD |
| Change In Working Capital | -10,360,000USD | -8,820,000USD | -6,294,000USD | -35,150,000USD | 11,854,000USD | -2,798,000USD | 11,778,000USD | 1,607,000USD |
| Total Cash From Operating Activities | 28,626,000USD | -36,981,000USD | -47,023,000USD | -102,891,000USD | -95,535,000USD | -80,558,000USD | -104,346,000USD | -56,279,000USD |
| Capital Expenditures | -696,000USD | -868,000USD | -2,263,000USD | -524,000USD | -1,085,000USD | -377,000USD | -1,107,000USD | -1,510,000USD |
| Free Cash Flow | 27,930,000USD | -37,849,000USD | -49,286,000USD | -103,415,000USD | -96,620,000USD | -80,935,000USD | -105,453,000USD | -57,789,000USD |
| Investments | 0USD | 4,883,000USD | -6,004,000USD | 34,461,000USD | 60,580,000USD | -101,773,000USD | -102,472,000USD | -68,851,000USD |
| Total Cashflows From Investing Activities | -696,000USD | 4,883,000USD | -6,004,000USD | 34,461,000USD | 97,964,000USD | -27,405,000USD | -2,383,000USD | -68,261,000USD |
| Net Borrowings | 0USD | 38,169,000USD | 0USD | 102,718,000USD | 102,718,000USD | 94,839,000USD | 60,000,000USD | 35,000,000USD |
| Total Cash From Financing Activities | 11,389,000USD | 36,168,000USD | -1,613,000USD | 127,473,000USD | 27,247,000USD | 126,064,000USD | 80,530,000USD | 128,211,000USD |
| Sale Purchase Of Stock | -10,876,000USD | -3,734,000USD | -1,009,000USD | -468,000USD | -534,000USD | -63,000USD | -4,465,000USD | 98,325,000USD |
| Issuance Of Capital Stock | 9,167,000USD | 0USD | 0USD | 30,000,000USD | 27,000,000USD | 65,891,000USD | 61,692,000USD | 102,763,000USD |
| Change In Cash | 39,319,000USD | 4,070,000USD | -54,640,000USD | 59,043,000USD | 29,673,000USD | 18,079,000USD | -26,197,000USD | 3,671,000USD |
| Begin Period Cash Flow | 75,744,000USD | 71,674,000USD | 126,314,000USD | 67,271,000USD | 37,598,000USD | 19,519,000USD | 45,716,000USD | 42,045,000USD |
| End Period Cash Flow | 115,063,000USD | 75,744,000USD | 71,674,000USD | 126,314,000USD | 67,271,000USD | 37,598,000USD | 19,519,000USD | 45,716,000USD |
| Other Cashflows From Financing Activities | 11,389,000USD | 1,733,000USD | -604,000USD | 288,487,000USD | 50,959,000USD | 180,968,000USD | 118,987,000USD | 4,105,000USD |
| Unclassified Financing Cash Flow | 10,876,000USD | — | — | -116,214,000USD | -100,807,000USD | -54,037,000USD | -33,308,000USD | -9,219,000USD |
| Unclassified Operating Cash Flow | — | -2,268,000USD | -1,249,000USD | -1,424,000USD | 1,115,000USD | — | — | — |
| Unclassified Investing Cash Flow | — | — | 2,263,000USD | -34,461,000USD | 65,497,000USD | 75,122,000USD | 102,472,000USD | 68,851,000USD |
| Change To Liabilities | — | — | — | -4,318,000USD | 5,527,000USD | -2,486,000USD | 4,737,000USD | -1,110,000USD |
| Dividends Paid | — | — | — | -147,050,000USD | -25,089,000USD | -95,643,000USD | -60,684,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | 34,985,000USD | -27,028,000USD | -377,000USD | -1,276,000USD | -66,751,000USD |
| Exchange Rate Changes | — | — | — | — | — | -22,000USD | 2,000USD | — |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 18,079,000USD | -26,197,000USD | 3,671,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Gvoke | 22,549,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Keveyis | 11,675,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product Other | 0 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Recorlev | 56,780,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Royalty Contract And Other Revenue | 1,096,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Gvoke | 20,800,000 | USD | 0001867096-26-000030 |
| Q1 2026Quarterly · 2026-03-31 | Product | Keveyis | 11,886,000 | USD | 0001867096-26-000030 |
| Q1 2026Quarterly · 2026-03-31 | Product | Recorlev | 49,768,000 | USD | 0001867096-26-000030 |
| Q1 2026Quarterly · 2026-03-31 | Product | Royalty Contract And Other Revenue | 673,000 | USD | 0001867096-26-000030 |
| Q4 2025Quarterly · 2025-12-31 | Product | Gvoke | 24,645,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Keveyis | 12,800,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product Other | 651,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Recorlev | 45,334,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Royalty Contract And Other Revenue | 2,377,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Gvoke | 94,108,000 | USD | 0001867096-26-000016 |
| FY 2025Yearly · 2025-12-31 | Product | Keveyis | 47,649,000 | USD | 0001867096-26-000016 |
| FY 2025Yearly · 2025-12-31 | Product | Product Other | 1,963,000 | USD | 0001867096-26-000016 |
| FY 2025Yearly · 2025-12-31 | Product | Recorlev | 139,283,000 | USD | 0001867096-26-000016 |
| FY 2025Yearly · 2025-12-31 | Product | Royalty Contract And Other Revenue | 8,842,000 | USD | 0001867096-26-000016 |
| Q3 2025Quarterly · 2025-09-30 | Product | Gvoke | 25,151,000 | USD | 0001867096-25-000159 |
| Q3 2025Quarterly · 2025-09-30 | Product | Keveyis | 11,937,000 | USD | 0001867096-25-000159 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product Other | 0 | USD | 0001867096-25-000159 |
| Q3 2025Quarterly · 2025-09-30 | Product | Recorlev | 36,975,000 | USD | 0001867096-25-000159 |
| Q3 2025Quarterly · 2025-09-30 | Product | Royalty Contract And Other Revenue | 317,000 | USD | 0001867096-25-000159 |
| Q2 2025Quarterly · 2025-06-30 | Product | Gvoke | 23,467,000 | USD | 0001867096-25-000136 |
| Q2 2025Quarterly · 2025-06-30 | Product | Keveyis | 11,485,000 | USD | 0001867096-25-000136 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product Other | 1,312,000 | USD | 0001867096-25-000136 |
| Q2 2025Quarterly · 2025-06-30 | Product | Recorlev | 31,444,000 | USD | 0001867096-25-000136 |
| Q2 2025Quarterly · 2025-06-30 | Product | Royalty Contract And Other Revenue | 3,831,000 | USD | 0001867096-25-000136 |
| Q1 2025Quarterly · 2025-03-31 | Product | Gvoke | 20,845,000 | USD | 0001867096-26-000030 |
| Q1 2025Quarterly · 2025-03-31 | Product | Keveyis | 11,427,000 | USD | 0001867096-26-000030 |
| Q1 2025Quarterly · 2025-03-31 | Product | Recorlev | 25,530,000 | USD | 0001867096-26-000030 |
| Q1 2025Quarterly · 2025-03-31 | Product | Royalty Contract And Other Revenue | 2,317,000 | USD | 0001867096-26-000030 |
| Q4 2024Quarterly · 2024-12-31 | Product | Gvoke | 23,262,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Keveyis | 11,124,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product Other | 0 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Recorlev | 22,614,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Royalty Contract And Other Revenue | 3,099,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Gvoke | 82,829,000 | USD | 0001867096-26-000016 |
| FY 2024Yearly · 2024-12-31 | Product | Keveyis | 49,530,000 | USD | 0001867096-26-000016 |
| FY 2024Yearly · 2024-12-31 | Product | Product Other | 0 | USD | 0001867096-26-000016 |
| FY 2024Yearly · 2024-12-31 | Product | Recorlev | 64,277,000 | USD | 0001867096-26-000016 |
| FY 2024Yearly · 2024-12-31 | Product | Royalty Contract And Other Revenue | 6,434,000 | USD | 0001867096-26-000016 |
| Q3 2024Quarterly · 2024-09-30 | Product | Gvoke | 22,942,000 | USD | 0001867096-25-000159 |
| Q3 2024Quarterly · 2024-09-30 | Product | Keveyis | 12,193,000 | USD | 0001867096-25-000159 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product Other | 0 | USD | 0001867096-25-000159 |
| Q3 2024Quarterly · 2024-09-30 | Product | Recorlev | 17,726,000 | USD | 0001867096-25-000159 |
| Q3 2024Quarterly · 2024-09-30 | Product | Royalty Contract And Other Revenue | 1,407,000 | USD | 0001867096-25-000159 |
| FY 2023Yearly · 2023-12-31 | Product | Gvoke | 67,045,000 | USD | 0001867096-26-000016 |
| FY 2023Yearly · 2023-12-31 | Product | Keveyis | 56,772,000 | USD | 0001867096-26-000016 |
| FY 2023Yearly · 2023-12-31 | Product | Product Other | 0 | USD | 0001867096-26-000016 |
| FY 2023Yearly · 2023-12-31 | Product | Recorlev | 29,547,000 | USD | 0001867096-26-000016 |
| FY 2023Yearly · 2023-12-31 | Product | Royalty Contract And Other Revenue | 10,550,000 | USD | 0001867096-26-000016 |
| FY 2022Yearly · 2022-12-31 | Product | Gvoke | 52,527,000 | USD | 0001867096-25-000039 |
| FY 2022Yearly · 2022-12-31 | Product | Keveyis | 49,307,000 | USD | 0001867096-25-000039 |
| FY 2022Yearly · 2022-12-31 | Product | Recorlev | 7,429,000 | USD | 0001867096-25-000039 |
| FY 2022Yearly · 2022-12-31 | Product | Royalty Contract And Other Revenue | 985,000 | USD | 0001867096-25-000039 |
| FY 2021Yearly · 2021-12-31 | Product | Gvoke | 38,917,000 | USD | 0001867096-24-000031 |
| FY 2021Yearly · 2021-12-31 | Product | Keveyis | 10,363,000 | USD | 0001867096-24-000031 |
| FY 2021Yearly · 2021-12-31 | Product | Recorlev | 0 | USD | 0001867096-24-000031 |
| FY 2021Yearly · 2021-12-31 | Product | Royalty Contract And Other Revenue | 310,000 | USD | 0001867096-24-000031 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.